Bioshares analysis: 60 of 101 biotech firms lifted market cap in 3 years, as Oventus reaches distribution deal

BIOTECHNOLOGY can be risky, but a new study shows that almost 60 per cent of life-science companies have grown in stockmarket size over the past three years.

At least 25 out of 101 surveyed companies had doubled their market capitalisation, the study by sector analysts Bioshares found. Fifteen of the 101 companies listed since June 2015 had at least tripled.

Read more